{"meta":{"query_hash":"4a1837ba89dc","filters":{"venue":"Pharmacology &amp Pharmacy"},"cohort_total":9,"direct_labels_cover":0,"predictions_cover":9,"exported":9,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4a1837ba89dc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmacology+%26amp+Pharmacy"},"results":[{"id":"W1740921288","doi":"10.4236/pp.2015.69046","title":"Platelet-Activating Factor Induces Du-al-Specificity Phosphatase 1 and 5 Gene Expression","year":2015,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Dual-specificity phosphatase; MAPK/ERK pathway; Cell biology; Platelet-activating factor; Kinase; Phosphatase; p38 mitogen-activated protein kinases; Wortmannin; MAPK cascade; Chemistry; Signal transduction; Proinflammatory cytokine; PI3K/AKT/mTOR pathway; Phosphorylation; Biology; Molecular biology; Inflammation; Endocrinology; Immunology","score_opus":0.054088356853382175,"score_gpt":0.33311262351942383,"score_spread":0.27902426666604163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740921288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867813,0.0041104667,0.005693429,0.0001704595,0.000058316888,0.00005785881,0.00077649514,0.00008301007,0.002268573],"genre_scores_gemma":[0.98772067,0.0016527795,0.0040831086,0.00016134161,0.00002821214,0.00007457185,0.001557596,0.000016608788,0.0047049527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998024,0.000042226227,0.000014200537,0.000037670496,0.00003746821,0.00006614228],"domain_scores_gemma":[0.99988174,0.00003128658,0.000022796361,0.000015949157,0.000017140545,0.000031085678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015567789,0.00031039026,0.00021375688,0.00031014622,0.00012981663,0.0002242799,0.00008758256,0.00019891324,0.0012584123],"category_scores_gemma":[0.00013446053,0.00017091434,0.0004978644,0.00018330383,0.0001561791,0.00011390603,0.00021491683,0.00043039542,0.00037272403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011331797,0.000025012421,0.0001529516,0.000038044866,0.0000036247018,0.000055837543,0.000017394404,0.000030439112,0.998245,0.00008838242,0.00004287019,0.0011871839],"study_design_scores_gemma":[0.000018983561,0.00051577255,0.01277553,0.000009380576,0.000016091684,0.00033941653,0.000052909785,0.0010695254,0.9810901,0.00011758671,0.0039900863,0.000004592997],"about_ca_topic_score_codex":0.0006811902,"about_ca_topic_score_gemma":0.00100521,"teacher_disagreement_score":0.0012584123,"about_ca_system_score_codex":0.0002664446,"about_ca_system_score_gemma":0.00016122665,"threshold_uncertainty_score":0.004209757},"labels":[],"label_agreement":null},{"id":"W1982218890","doi":"10.4236/pp.2013.43041","title":"Quantifying Isotibolone in Raw Materials of Tibolone","year":2013,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"X-ray Diffraction in Crystallography","field":"Materials Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Laboratório Nacional de Luz Síncrotron; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Consejo Superior de Investigaciones Científicas; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Tibolone; Raw material; Steroid; Synchrotron; Materials science; Menopause; Chemistry; Medicine; Internal medicine; Physics; Organic chemistry; Optics; Hormone","score_opus":0.0626697383991371,"score_gpt":0.3680589716023963,"score_spread":0.3053892332032592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982218890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.859656,0.020856822,0.09228111,0.00048125043,0.00034049887,0.0005815247,0.0048600906,0.0009442098,0.01999857],"genre_scores_gemma":[0.8826324,0.00915213,0.09133107,0.00043546906,0.0000823542,0.000493242,0.00562721,0.00034985234,0.009896228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998492,0.00020387734,0.000111905574,0.00019652143,0.0008978554,0.0000978285],"domain_scores_gemma":[0.99926597,0.00017532326,0.00011162604,0.000079725716,0.00033094716,0.00003646651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005451709,0.00078634673,0.00040208717,0.0018924403,0.00046698382,0.00067509996,0.00056295266,0.0007491755,0.0034101899],"category_scores_gemma":[0.0011275251,0.00032583103,0.00038825945,0.0012777215,0.00043898946,0.00050677045,0.0003051653,0.00080566976,0.0011645068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080351565,0.00002622692,0.00059244054,0.00015405938,0.000011725714,0.000091316164,0.000059417165,0.00010865813,0.99448884,0.00013943546,0.00007790206,0.004169529],"study_design_scores_gemma":[0.000011784145,0.00015919266,0.0035277905,0.00004323166,0.000032210297,0.0002315323,0.00012218501,0.0007023223,0.98933357,0.00014063998,0.005678233,0.000017366181],"about_ca_topic_score_codex":0.0012122823,"about_ca_topic_score_gemma":0.0036050845,"teacher_disagreement_score":0.0034101899,"about_ca_system_score_codex":0.0002971474,"about_ca_system_score_gemma":0.00037517975,"threshold_uncertainty_score":0.01140821},"labels":[],"label_agreement":null},{"id":"W1987844033","doi":"10.4236/pp.2014.512121","title":"Anti-Inflammatory and Analgesic Effects of Aqueous Extract of Stem Bark of <i>Ceiba pentandra</i> Gaertn","year":2014,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Ethnobotanical and Medicinal Plants Studies","field":"Agricultural and Biological Sciences","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Universitaire de la Francophonie","keywords":"Ceiba; Bark (sound); Analgesic; Traditional medicine; Carrageenan; Aqueous extract; Anti-inflammatory; Chemistry; Pharmacology; Medicine; Biology; Biochemistry","score_opus":0.03344491972123044,"score_gpt":0.29644405167804966,"score_spread":0.26299913195681923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987844033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233913,0.003047968,0.0008466109,0.00012986617,0.00003107051,0.000043250944,0.00018947548,0.000046825266,0.0033257646],"genre_scores_gemma":[0.993472,0.0018960343,0.0013158295,0.00008911616,0.000018801831,0.000025858835,0.0003184854,0.000007670072,0.0028562369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997663,0.0000032125802,0.0000020578248,0.0000033384338,0.000006480635,0.000008299599],"domain_scores_gemma":[0.99996054,0.000008000968,0.000008562584,0.0000033433314,0.000005995169,0.000013564829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044669316,0.00039122417,0.00023784449,0.00030337807,0.00012903701,0.00011990106,0.00011118772,0.0001775561,0.0014521091],"category_scores_gemma":[0.00008494354,0.000090105714,0.00015769318,0.00013452656,0.00017333742,0.00012018873,0.000104447434,0.00038456547,0.00023437437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047953162,0.00013482456,0.00016311392,0.00009139396,0.000007340816,0.000089980465,0.000018282331,0.000069086076,0.99346405,0.000045931673,0.000041394153,0.005395045],"study_design_scores_gemma":[0.00026163796,0.006949864,0.018100739,0.000061664665,0.000119675926,0.0007979857,0.00007639373,0.00056043954,0.9689603,0.00012400506,0.0039738216,0.000013472881],"about_ca_topic_score_codex":0.0008991795,"about_ca_topic_score_gemma":0.0012135722,"teacher_disagreement_score":0.0014521091,"about_ca_system_score_codex":0.00009277769,"about_ca_system_score_gemma":0.00017940202,"threshold_uncertainty_score":0.004857838},"labels":[],"label_agreement":null},{"id":"W1988963086","doi":"10.4236/pp.2014.510107","title":"Non-Immunosuppressant Medication Use in Heart Transplant Patients: A Guide for Pharmacists","year":2014,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Intensive care medicine; Dyslipidemia; Immunosuppression; Pharmacy; Tacrolimus; Internal medicine; Transplantation; Nursing; Disease","score_opus":0.05414491413241482,"score_gpt":0.4110840291726031,"score_spread":0.35693911504018827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988963086","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019685693,0.10483142,0.062935516,0.62859315,0.0049242824,0.005448036,0.0064271037,0.0061425483,0.16101226],"genre_scores_gemma":[0.06093951,0.30153102,0.35262826,0.15465865,0.006527182,0.010556483,0.00526335,0.00056242285,0.10733316],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984138,0.0005284782,0.00037752066,0.00008565675,0.00050331646,0.00009120366],"domain_scores_gemma":[0.9963553,0.0011921905,0.0005980936,0.00011506254,0.00106234,0.0006770086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026503783,0.0008866083,0.001221201,0.0026332992,0.0012690943,0.0022955986,0.0013563139,0.0032293024,0.013760144],"category_scores_gemma":[0.007387025,0.0006431659,0.0009966785,0.0016258407,0.0005686724,0.0047815987,0.0021969979,0.00422481,0.01360037],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057755035,0.0009875504,0.008475975,0.0012327356,0.00003246819,0.0018596487,0.0014139073,0.0002800785,0.00052580266,0.0013373245,0.54589415,0.4379026],"study_design_scores_gemma":[0.00027937835,0.0009678801,0.028468153,0.008367973,0.0000657237,0.018688377,0.0061411094,0.0012716552,0.00052990665,0.01212947,0.9229191,0.00017131529],"about_ca_topic_score_codex":0.004335541,"about_ca_topic_score_gemma":0.013890834,"teacher_disagreement_score":0.013760144,"about_ca_system_score_codex":0.0010532174,"about_ca_system_score_gemma":0.004666828,"threshold_uncertainty_score":0.04603231},"labels":[],"label_agreement":null},{"id":"W2021387649","doi":"10.4236/pp.2010.12007","title":"Rational Drug Delineation: A Global Sensitivity Approach Based on Therapeutic Tolerability to Deviations in Execution","year":2010,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Mitacs; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Tolerability; Drug; Medicine; Therapeutic index; Pharmacology; Psychology; Adverse effect","score_opus":0.046110117826040534,"score_gpt":0.39281269595978036,"score_spread":0.34670257813373984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021387649","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1375688,0.00079416716,0.85184366,0.0006160224,0.000059437352,0.0010106852,0.0006488551,0.0008268816,0.0066314377],"genre_scores_gemma":[0.8366979,0.00024775762,0.16073659,0.00023175734,0.00006987964,0.00047205374,0.0005101305,0.00010137966,0.00093253667],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9846868,0.008548789,0.001275194,0.002269289,0.0026808416,0.0005391877],"domain_scores_gemma":[0.9574513,0.034218222,0.0028553016,0.0026907842,0.002347904,0.00043653895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023037286,0.002820635,0.0032045373,0.0076452224,0.0008993573,0.003890705,0.0013948134,0.0015841216,0.0030057086],"category_scores_gemma":[0.04664285,0.0006365027,0.0034729296,0.0018726046,0.0021715455,0.0031210128,0.0024850233,0.001533287,0.00027909435],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011568803,0.00027761576,0.043126717,0.0007389678,0.0015300602,0.00054592016,0.0006285525,0.7704909,0.006910515,0.02226735,0.0016127477,0.15071371],"study_design_scores_gemma":[0.00006269293,0.00073270965,0.00901744,0.000095615265,0.0003850105,0.00042787107,0.00023715185,0.9511644,0.0041389037,0.032134358,0.0014581216,0.00014580533],"about_ca_topic_score_codex":0.0027397468,"about_ca_topic_score_gemma":0.0013613735,"teacher_disagreement_score":0.023037286,"about_ca_system_score_codex":0.002376302,"about_ca_system_score_gemma":0.0017571645,"threshold_uncertainty_score":0.12183428},"labels":[],"label_agreement":null},{"id":"W2064041069","doi":"10.4236/pp.2014.58091","title":"<i>In Vitro</i> Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines","year":2014,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cannabidiol; DU145; LNCaP; Pharmacology; Cannabinoid receptor; Prostate cancer; Cannabinoid; Cancer research; Cancer; Medicine; Cannabinoid receptor type 2; Internal medicine; Receptor; Cannabis; Agonist","score_opus":0.04314107433791759,"score_gpt":0.3777698428180739,"score_spread":0.3346287684801563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064041069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273133,0.019193556,0.016426152,0.00084816123,0.0005239132,0.00042938185,0.0100707095,0.0007384655,0.024456352],"genre_scores_gemma":[0.92077094,0.014033732,0.02382224,0.00037124337,0.00015089373,0.00064936385,0.013889694,0.00017689413,0.026134986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970526,0.00006256328,0.000047273457,0.00004705764,0.00007348663,0.00006431299],"domain_scores_gemma":[0.9998771,0.00003831251,0.00001603455,0.000019121642,0.000027553815,0.000021772887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029360256,0.0006747028,0.0006191611,0.00042335392,0.0003430399,0.00025254235,0.00034989713,0.0002332955,0.0036150534],"category_scores_gemma":[0.00017632112,0.00021316622,0.00053511275,0.00089429825,0.00028915564,0.0002593335,0.0002456258,0.0012408273,0.0016546194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073770963,0.00044257846,0.00020688906,0.00051273603,0.000023672434,0.00020668772,0.00013863247,0.00060876773,0.98875135,0.00035528044,0.0007332868,0.007282311],"study_design_scores_gemma":[0.000036058424,0.0007759376,0.0011959133,0.000018298511,0.00002698288,0.00011434498,0.000026924605,0.0005639021,0.99088144,0.00005788447,0.0062936,0.000008733191],"about_ca_topic_score_codex":0.0034824642,"about_ca_topic_score_gemma":0.004545274,"teacher_disagreement_score":0.0036150534,"about_ca_system_score_codex":0.00035446524,"about_ca_system_score_gemma":0.0005543058,"threshold_uncertainty_score":0.012093544},"labels":[],"label_agreement":null},{"id":"W2253806664","doi":"10.4236/pp.2016.71010","title":"Evaluation of the Management of Hyperlipidemia and Hypertension in an Outpatient Cardiac Transplant Clinic","year":2016,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Hyperlipidemia; Atorvastatin; Internal medicine; Outpatient clinic; Blood pressure; Discontinuation; Coronary artery disease; Transplantation; Heart failure; Cardiology; Diabetes mellitus; Endocrinology","score_opus":0.14756546269203064,"score_gpt":0.4428828387056157,"score_spread":0.29531737601358504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253806664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978975,0.00036652273,0.00008501624,0.00023968397,0.000012363791,0.000037660626,0.00018263067,0.000014133474,0.0011644748],"genre_scores_gemma":[0.9988667,0.00026185144,0.00027283322,0.00021638858,0.00003591351,0.000022393999,0.0001467221,0.0000029748182,0.00017427237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993642,0.00018438158,0.00009746175,0.000073771305,0.00015855278,0.000121620214],"domain_scores_gemma":[0.99652123,0.0004966506,0.0016179229,0.000053946555,0.00035193696,0.0009583902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000681423,0.00018379754,0.00029033655,0.00073374936,0.0007853273,0.00059053116,0.00037527757,0.00045144768,0.0028089988],"category_scores_gemma":[0.0025951182,0.00020500083,0.0002108334,0.0005529233,0.00023464515,0.00036663847,0.00033425563,0.00063875027,0.00031804928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000656098,0.00018750409,0.99383074,0.000030791864,0.000010777742,0.0013245869,0.00025764853,0.00002251486,0.0005185959,0.000008219159,0.0004459873,0.0032970961],"study_design_scores_gemma":[0.000019602032,0.00052352407,0.9921942,0.00004200693,0.000022148342,0.0054532564,0.0008278987,0.00019353782,0.00021761225,0.00001332128,0.0004860212,0.00000683729],"about_ca_topic_score_codex":0.004284071,"about_ca_topic_score_gemma":0.008461434,"teacher_disagreement_score":0.004284071,"about_ca_system_score_codex":0.0006592557,"about_ca_system_score_gemma":0.0008095549,"threshold_uncertainty_score":0.00939703},"labels":[],"label_agreement":null},{"id":"W3084469564","doi":"10.4236/pp.2020.119019","title":"The Pandemic COVID-19 and the Auspicious Role of Frontier Pharmacists against This Global Threat","year":2020,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Pandemic; Medicine; Pharmacist; MEDLINE; Family medicine; Coronavirus disease 2019 (COVID-19); Personal protective equipment; Health care; Pharmacy; Nursing; Political science; Disease; Infectious disease (medical specialty)","score_opus":0.08754882433478146,"score_gpt":0.4777586291093782,"score_spread":0.39020980477459677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084469564","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02003557,0.7764595,0.0008835548,0.17620762,0.0034974345,0.000113151546,0.00038461378,0.000041321295,0.022377241],"genre_scores_gemma":[0.1876604,0.7375857,0.003488069,0.06237482,0.004364685,0.00015014135,0.00042878493,0.000025354793,0.0039220504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996323,0.0019782044,0.00038477202,0.00024136422,0.0007079501,0.0003645979],"domain_scores_gemma":[0.9863197,0.0065412293,0.0030514277,0.00034080443,0.0023019318,0.001444862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004999881,0.00034765026,0.0006527114,0.0012802937,0.0011488742,0.0033261771,0.00057502097,0.0027495814,0.0068108663],"category_scores_gemma":[0.015335856,0.00017180237,0.00076667516,0.001781355,0.0013059779,0.005053648,0.0026708497,0.0031276392,0.0007180712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067142997,0.00022435213,0.022497617,0.063356735,0.0009477876,0.0026974054,0.0068774526,0.00043593656,0.0020551076,0.021383611,0.14481004,0.7340425],"study_design_scores_gemma":[0.00020949385,0.0007622133,0.041549798,0.090874754,0.000948916,0.005663108,0.025940688,0.00037175484,0.0007466297,0.018868461,0.81393105,0.00013315503],"about_ca_topic_score_codex":0.0038869865,"about_ca_topic_score_gemma":0.008036072,"teacher_disagreement_score":0.0068108663,"about_ca_system_score_codex":0.0015103474,"about_ca_system_score_gemma":0.008216463,"threshold_uncertainty_score":0.02644217},"labels":[],"label_agreement":null},{"id":"W3196544009","doi":"10.4236/pp.2021.128014","title":"Development of a Method for Identification and Quantification of Sulfadiazine and Pyrimethamine in Serum of Congenital Toxoplasmosis Pediatric Patients","year":2021,"lang":"en","type":"article","venue":"Pharmacology &amp Pharmacy","topic":"Toxoplasma gondii Research Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Comisión de Investigaciones Científicas; Agencia Nacional de Promoción Científica y Tecnológica; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Sulfadiazine; Pyrimethamine; Toxoplasmosis; Chromatography; Medicine; Congenital toxoplasmosis; Toxoplasma gondii; Therapeutic drug monitoring; Atovaquone; Pharmacology; Chemistry; Drug; Antibiotics; Malaria; Virology; Immunology; Chloroquine","score_opus":0.04662671394815708,"score_gpt":0.37705930172361934,"score_spread":0.33043258777546225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196544009","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7433606,0.018559428,0.22652043,0.0009180388,0.0004966919,0.0013760546,0.0017155688,0.0017269042,0.005326245],"genre_scores_gemma":[0.739678,0.004537353,0.2494093,0.0007390641,0.00010093839,0.0009170041,0.001261854,0.000052525596,0.0033039032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978517,0.00062594475,0.00015251331,0.0003601687,0.000912617,0.00009704066],"domain_scores_gemma":[0.999337,0.00017492603,0.00015772294,0.00004355067,0.00023357537,0.00005315684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012493863,0.00078823284,0.00050043483,0.0013470356,0.0003430633,0.00047646684,0.00057806226,0.0011841395,0.0006063241],"category_scores_gemma":[0.001379312,0.0005148216,0.00043716416,0.00051695894,0.00042317316,0.00027090553,0.000490515,0.0007791908,0.00046440336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029942428,0.00024760203,0.011588164,0.0003446375,0.000089858375,0.00022202525,0.00018183459,0.0004147503,0.9527067,0.00018421291,0.0003459006,0.033374965],"study_design_scores_gemma":[0.00010124525,0.0024731061,0.03319351,0.00011861562,0.00013184435,0.004054703,0.0001535807,0.009300312,0.94269234,0.00020896955,0.007506306,0.00006539678],"about_ca_topic_score_codex":0.0009475428,"about_ca_topic_score_gemma":0.0019494643,"teacher_disagreement_score":0.0013470356,"about_ca_system_score_codex":0.00039188354,"about_ca_system_score_gemma":0.0009948423,"threshold_uncertainty_score":0.006607473},"labels":[],"label_agreement":null}]}